title: Agomelatine reversal of escitalopram-induced apathy: a case report.
authors.forename: Domenico
authors.initials: D
authors.lastname: De Berardis
authors.forename: Alessandro
authors.initials: A
authors.lastname: Valchera
authors.forename: Michele
authors.initials: M
authors.lastname: Fornaro
authors.forename: Nicola
authors.initials: N
authors.lastname: Serroni
authors.forename: Stefano
authors.initials: S
authors.lastname: Marini
authors.forename: Francesco Saverio
authors.initials: FS
authors.lastname: Moschetta
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinotti
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Giannantonio
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000368:Aged; D057565:Apathy; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D009042:Motivation / Q000187:drug effects; D009483:Neuropsychological Tests; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D015283:Citalopram; D006993:Hypnotics and Sedatives; D017367:Selective Serotonin Reuptake Inhibitors; C084711:agomelatine; D009281:Naphthalenes